Sun Pharma declares five-year positive results for ILUMYA (tildrakizumab-asmn)
ILUMYA is approved for adults with moderate-to-severe plaque psoriasis and is being evaluated for other possible uses
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.